Company news

Aurobindo Pharma Ltd news in 2026

Aurobindo Pharma Ltd's news releases, calls and decks from 2026, newest first.

View company

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 03, 2026, titled "Aurobindo Pharma receives USFDA Final Approval for Perampanel Tablets, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg".

October 3, 2026

Aurobindo Pharma Ltd Press Release Sep 30 2026

September 30, 2026

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 30, 2026, titled "Acrotech Biopharma Launches ADQUEY in the U.S. and Establishes Dedicated Dermatology Business".

September 30, 2026

Aurobindo Pharma Ltd Press Release Sep 15 2026

September 15, 2026

Aurobindo Pharma Ltd Press Release Aug 31 2026

August 31, 2026

Aurobindo Pharma Ltd Press Release Aug 05 2026

August 5, 2026

Aurobindo Pharma Ltd Press Release Jul 24 2026

July 24, 2026

Aurobindo Pharma Ltd Press Release Jun 22 2026

June 21, 2026

Press Release Jun 04 2026

June 4, 2026

Press Release Jun 03 2026

June 3, 2026

Press Release May 21 2026

May 21, 2026

Press Release Apr 17 2026

April 17, 2026

Press Release Apr 07 2026

April 7, 2026

Press Release Apr 06 2026

April 6, 2026

Press Release Mar 04 2026

March 4, 2026

Press Release Feb 26 2026

February 26, 2026

Press Release Feb 13 2026

February 13, 2026

Press Release Feb 09 2026

February 9, 2026

Decks in 2026